Literature DB >> 29920796

Diagnostic cut-off of Aspergillus fumigatus-specific IgG in the diagnosis of chronic pulmonary aspergillosis.

Inderpaul Singh Sehgal1, Hansraj Choudhary2, Sahajal Dhooria1, Ashutosh Nath Aggarwal1, Mandeep Garg3, Arunaloke Chakrabarti2, Ritesh Agarwal1.   

Abstract

Aspergillus fumigatus-specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut-off value for A. fumigatus-specific IgG remains unknown. We included consecutive treatment-naïve subjects with chronic cavitary pulmonary aspergillosis (CCPA, cases). The controls were subjects with treated pulmonary tuberculosis, who had residual radiological abnormality and minimal symptoms. The diagnosis of CCPA was based on consistent clinicoradiological features along with demonstration of Aspergillus infection (growth of Aspergillus in sputum or bronchoalveolar lavage fluid [BALF] culture; serum or BALF galactomannan index >0.5 and >1, respectively). For determining the cut-off of A. fumigatus-specific IgG (Phadia), subjects were randomly classified as derivation (two-thirds) and validation (one-third) cohort. One hundred and thirty-seven cases and 50 controls were included. The best cut-off value for A. fumigatus-specific IgG (derivation cohort) was 27.3 mgA/L (AUROC, 0.976) at a sensitivity and specificity of 95.6% and 100%, respectively. Using a cut-off of 27 mgA/L, the sensitivity and specificity in the validation cohort was 91.3% and 100%, respectively. In contrast, the sensitivity of Aspergillus precipitins was only 25.5%. At a cut-off value of 27 mgA/L, A. fumigatus-specific IgG is a reliable test with high sensitivity and specificity in the diagnosis of CPA. More studies are required to confirm our findings.
© 2018 Blackwell Verlag GmbH.

Entities:  

Keywords:  ELISA; IgG; ImmunoCap; aspergillosis; chronic pulmonary aspergillosis

Mesh:

Substances:

Year:  2018        PMID: 29920796     DOI: 10.1111/myc.12815

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  10 in total

1.  Utility of Serum and Bronchoalveolar Lavage Fluid Galactomannan in Diagnosis of Chronic Pulmonary Aspergillosis.

Authors:  Inderpaul Singh Sehgal; Sahajal Dhooria; Hansraj Choudhary; Ashutosh Nath Aggarwal; Mandeep Garg; Arunaloke Chakrabarti; Ritesh Agarwal
Journal:  J Clin Microbiol       Date:  2019-02-27       Impact factor: 5.948

2.  Evaluation of LDBio Aspergillus ICT Lateral Flow Assay for IgG and IgM Antibody Detection in Chronic Pulmonary Aspergillosis.

Authors:  Elizabeth Stucky Hunter; Malcolm D Richardson; David W Denning
Journal:  J Clin Microbiol       Date:  2019-08-26       Impact factor: 5.948

3.  Accuracy of serological tests for diagnosis of chronic pulmonary aspergillosis: A systematic review and meta-analysis.

Authors:  Cláudia Elizabeth Volpe Chaves; Sandra Maria do Valle Leone de Oliveira; James Venturini; Antonio Jose Grande; Tatiane Fernanda Sylvestre; Rinaldo Poncio Mendes; Anamaria Mello Miranda Paniago
Journal:  PLoS One       Date:  2020-03-17       Impact factor: 3.240

4.  Prospective Evaluation of Aspergillus fumigatus-Specific IgG in Patients With Cystic Fibrosis.

Authors:  Patience Eschenhagen; Claudia Grehn; Carsten Schwarz
Journal:  Front Cell Infect Microbiol       Date:  2021-01-22       Impact factor: 5.293

5.  Effect of patient immunodeficiencies on the diagnostic performance of serological assays to detect Aspergillus-specific antibodies in chronic pulmonary aspergillosis.

Authors:  Elizabeth Stucky Hunter; Bayu Wilopo; Malcolm D Richardson; Chris Kosmidis; David W Denning
Journal:  Respir Med       Date:  2021-01-12       Impact factor: 3.415

6.  Standardization of Aspergillus IgG diagnostic cutoff in Nigerians.

Authors:  Rita O Oladele; Akaninyene A Otu; Oluwaseyi J Balogun; Oladayo M Babalola; Augustina O Nwosu; Iriagbonse Iyabo Osaigbovo; Titilayo Gbajabiamila; Nicholas K Irurhe; Samuel A Fayemiwo; Shuwaram A Shettima; Nkolika Stella Uwaezuoke; Chinagozi Precious Edwin; Toyese Stephen Ayanbeku; Joy U Okaa; Charles John Elikwu; David W Denning; Phyllis J Kanki; Folasade T Ogunsola
Journal:  Ther Adv Infect Dis       Date:  2021-10-09

7.  Non-fumigatus Aspergillus Infection Associated with a Negative Aspergillus Precipitin Test in Patients with Chronic Pulmonary Aspergillosis.

Authors:  Keita Takeda; Junko Suzuki; Akira Watanabe; Osamu Narumoto; Masahiro Kawashima; Yuka Sasaki; Hideaki Nagai; Katsuhiko Kamei; Hirotoshi Matsui
Journal:  J Clin Microbiol       Date:  2021-12-08       Impact factor: 5.948

8.  Chronic Pulmonary Aspergillosis: Burden, Clinical Characteristics and Treatment Outcomes at a Large Australian Tertiary Hospital.

Authors:  Olivier Despois; Sharon C-A Chen; Nicole Gilroy; Michael Jones; Peter Wu; Justin Beardsley
Journal:  J Fungi (Basel)       Date:  2022-01-25

9.  Efficacy of LD Bio Aspergillus ICT Lateral Flow Assay for Serodiagnosis of Chronic Pulmonary Aspergillosis.

Authors:  Animesh Ray; Mohit Chowdhury; Janya Sachdev; Prayas Sethi; Ved Prakash Meena; Gagandeep Singh; Immaculata Xess; Surabhi Vyas; Maroof Ahmad Khan; Sanjeev Sinha; David W Denning; Naveet Wig; Sushil Kumar Kabra
Journal:  J Fungi (Basel)       Date:  2022-04-14

10.  Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients.

Authors:  Qihong Yu; Jingdong He; Bin Xing; Xin Li; Hongyu Qian; Hong Zhang; Meilin Xu; Haiying Peng
Journal:  BMC Pulm Med       Date:  2020-04-15       Impact factor: 3.317

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.